Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca2+ release channel/ryanodine receptors  by Fajloun, Z. et al.
Chemical synthesis and characterization of maurocalcine, a scorpion
toxin that activates Ca2 release channel/ryanodine receptors
Z. Fajlouna;*, R. Kharratb, L. Chenc, C. Lecomtea, E. Di Luccioa, D. Bichetd, M. El Ayebb,
H. Rochata, P.D. Allene, I.N. Pessahc, M. De Waardd, J.M. Sabatiera
aLaboratoire de Biochimie, CNRS UMR 6560, IFR Jean Roche, Faculte¤ de Me¤decine Nord, Bd Pierre Dramard, 13916 Marseille Cedex 20, France
bLaboratoire des Venins et Toxines, Institut Pasteur de Tunis, P.O. Box 74, 1002 Belve¤de're, Tunis, Tunisia
cDepartment of Molecular Biosciences, School of Veterinary Medicine and Graduate Program in Neurosciences, One Shields Avenue,
University of California, Davis, CA 95616, USA
dLaboratoire de Neurobiologie des Canaux Ioniques, INSERM U464, IFR Jean Roche, Faculte¤ de Me¤decine Nord, Bd Pierre Dramard,
13916 Marseille Cedex 20, France
eDepartment of Anesthesia, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA
Received 3 January 2000; received in revised form 29 January 2000
Edited by Pierre Jolles
Abstract Maurocalcine is a novel toxin isolated from the venom
of the chactid scorpion Scorpio maurus palmatus. It is a 33-mer
basic peptide cross-linked by three disulfide bridges, which shares
82% sequence identity with imperatoxin A, a scorpion toxin from
the venom of Pandinus imperator. Maurocalcine is peculiar in
terms of structural properties since it does not possess any
consensus motif reported so far in other scorpion toxins. Due to
its low concentration in venom (0.5% of the proteins),
maurocalcine was chemically synthesized by means of an
optimized solid-phase method, and purified after folding/oxida-
tion by using both C18 reversed-phase and ion exchange high-
pressure liquid chromatographies. The synthetic product (sMCa)
was characterized. The half-cystine pairing pattern of sMCa was
identified by enzyme-based cleavage and Edman sequencing. The
pairings were Cys3-Cys17, Cys10-Cys21, and Cys16-Cys32. In
vivo, the sMCa was lethal to mice following intracerebroven-
tricular inoculation (LD50, 20 Wg/mouse). In vitro, electrophys-
iological experiments based on recordings of single channels
incorporated into planar lipid bilayers showed that sMCa
potently and reversibly modifies channel gating behavior of the
type 1 ryanodine receptor by inducing prominent subconductance
behavior.
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1. Introduction
Maurocalcine (MCa), a toxin from the venom of the Tuni-
sian chactid scorpion Scorpio maurus palmatus, is a highly
basic 33-mer peptide cross-linked by three disul¢de bridges
[1]. It shares about 82% sequence identity with imperatoxin
A (IpTx A) [2,3], a scorpion toxin from the venom of Pan-
dinus imperator. MCa and IpTx A, although they are likely to
adopt a grossly similar conformation, are peculiar in terms of
their structural properties since they do not possess any con-
sensus motif (which was reported to be shared by all scorpion
toxins and insect defensins), and therefore are not thought to
adopt the ‘common’ K/L sca¡old [4,5]. IpTx A was reported to
activate Ca2 release channel/ryanodine receptors of mamma-
lian skeletal (RyR1) and cardiac muscles (RyR2) [6,7]. To-
gether with inositol 1,4,5-triphosphate (IP3) receptors, RyR
controls the intracellular Ca2 permeability of various cell
types, and is central in the process of excitation^contraction
of muscle tissues [8]. Ligands such as toxins that speci¢cally
interact with RyR are molecular probes to investigate both
the structure of the receptor and its role in excitation^contrac-
tion coupling. In the present work, we have chemically syn-
thesized MCa by the Fmoc/t-butyl strategy [9], and carefully
characterized the folded synthetic product sMCa for its phys-
icochemical and electrophysiological properties. The disul¢de
bridge organization was formerly established by enzyme-based
cleavage of sMCa followed by analyses of the proteolytic
peptide fragments using mass spectrometry, amino acid con-
tent determination, and Edman sequencing techniques, as de-
scribed [10,11]. sMCa was tested in vivo for lethal activity to
[12], and by electrophysiology in vitro for its putative action
on Ca2 £ux through RyR1 channels incorporated into planar
bilayer lipid membranes. Our data demonstrate that sMCa is
a new toxin active on RyR1 and that it binds onto a site
di¡erent from that of ryanodine itself.
2. Materials and methods
2.1. Materials
N-K-Fmoc-L-amino acids, 4-hydroxymethylphenyloxy (HMP) resin,
and reagents used for peptide synthesis were obtained from Perkin-
Elmer. Solvents were analytical grade products from SDS. Enzymes
(trypsin, and endoproteinase Asp-N) were obtained from Boehringer
Mannheim.
2.2. Chemical synthesis of MCa and physicochemical characterization
of the synthetic product, sMCa
The sMCa was obtained by the solid-phase method [9] using an
automated peptide synthesizer (Model 433A, Applied Biosystems
Inc.). Peptide chains were assembled stepwise on 0.25 mEq of HMP
resin (1% cross-linked; 0.89 mEq of amino group/g) using 1 mmol of
N-K-£uorenylmethyloxycarbonyl (Fmoc) amino acid derivatives. The
side chain-protecting groups were: trityl for Cys and Asn; tert-butyl
(for Ser, Thr, Glu, and Asp; pentamethylchroman for Arg, and tert-
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butyloxycarbonyl for Lys. N-K-Amino groups were deprotected by
treatment with 18% and 20% (v/v) piperidine/N-methylpyrrolidone
for 3 and 8 min, respectively. The Fmoc-amino acid derivatives
were coupled (20 min) as their hydroxybenzotriazole active esters in
N-methylpyrrolidone (four-fold excess). After peptide chain assembly,
the peptide resin (about 1.8 g) was treated for 3 h at room temper-
ature with a mixture of tri£uoroacetic acid/H2O/thioanisole/ethanedi-
thiol (88:5:5:2, v/v) in the presence of crystalline phenol (2.25 g). The
peptide mixture was then ¢ltered, and the ¢ltrate was precipitated by
adding cold t-butylmethyl ether. The crude peptide was pelleted by
centrifugation (3000Ug ; 8 min) and the supernatant was discarded.
The reduced peptide was then dissolved in 200 mM Tris^HCl bu¡er,
pH 8.3, at a ¢nal concentration of 2.5 mM and stirred under air to
allow oxidation/folding (72 h, room temperature). The target product,
sMCa, was puri¢ed to homogeneity, ¢rst, by reversed-phase high-
pressure liquid chromatography (HPLC) (Perkin-Elmer, C18 Aqua-
pore ODS 20 Wm, 250U10 mm) by means of a 60-min linear gradient
of 0.08% (v/v) tri£uoroacetic acid (TFA)/0^30% acetonitrile in 0.1%
(v/v) TFA/H2O at a £ow rate of 6 ml/min (V= 230 nm). A second step
of puri¢cation of sMCa was achieved by ion exchange chromatogra-
phy on a carboxymethyl cellulose matrix using 10 mM (bu¡er A) and
500 mM (bu¡er B) sodium phosphate bu¡ers, pH 9 (60-min linear
gradient from 0 to 60% bu¡er B at a £ow rate of 1 ml/min). The
homogeneity and identity of sMCa was assessed by: (i) analytical C18
reversed-phase HPLC (Merck, C18 Lichrospher 5 Wm, 4U200 mm)
using a 60-min linear gradient of 0.08% (v/v) TFA/0^60% acetonitrile
in 0.1% (v/v) TFA/H2O at a £ow rate of 1 ml/min; (ii) amino acid
analysis after acidolysis (6 N HCl/2% (w/v) phenol, 20 h, 118‡C, N2
atmosphere); and (iii) mass determination by matrix-assisted laser
desorption ionization^time of £ight mass spectrometry.
2.3. Structural characterization of sMCa: assignment of half-cystine
pairings by enzyme-based cleavage and Edman sequencing analysis
sMCa (600 Wg) was incubated either with trypsin or with endopro-
teinase Asp-N at 10% (w/w) in 50 mM sodium phosphate, pH 7.4, for
20 h at 37‡C. The peptide fragments were then puri¢ed by analytical
reverse-phase HPLC (Merck, C18 Lichrospher 5 Wm, 4U200 mm) with
a 60-min linear gradient of 0.08% (v/v) TFA/0^60% acetonitrile in
0.1% (v/v) TFA/H2O at a £ow rate of 1 ml/min (V= 230 nm), and
freeze-dried prior to analysis. The peptide fragments were hydrolyzed
by acidolysis (6 N HCl/phenol) and their amino acid content was
analyzed (Beckman, System 6300 amino acid analyzer). The peptides
were further characterized by mass spectrometry analysis (RP-DE
Voyager, Perseptive Biosystems), and Edman sequencing using a
gas-phase microsequencer (Applied Biosystems 470A). In standard
HPLC conditions for analyzing phenylthiohydantoin (PTH) amino
acid derivatives, diPTH-cystine elutes at a retention time of 9.8 min.
2.4. Electrophysiological recordings
Cs current through single RyR1 channels incorporated into planar
lipid bilayers (BLM) was measured in an asymmetric CsCl (10:1 cis:
trans) solution. The BLM was formed from a mixture of phosphati-
dylethanolamine and phosphatidylcholine (5:2, w/w) at 30^50 mg/ml
in decane, across a 150^300 Wm aperture in a 1.0 ml polystyrene cup.
Sarcoplasmic reticulum (SR) vesicles were added to the cis side of the
chamber at a ¢nal concentration of 0.1^10 Wg/ml. The cis solution
contained 500 mM CsCl, V7 WM CaCl2, 20 mM HEPES, pH 7.4,
and the trans solution contained 50 mM CsCl, 7 WM free Ca2, 20 mM
HEPES, pH 7.4. The monovalent cation Cs was used as the perme-
ant ion instead of divalent cations (such as Ca2) because of its better
permeability through RyR1. After a single fusion event, sarcoplasmic
reticulum (SR) vesicles in the cis chamber were quickly removed by
perfusion with 9U volume of cis solution. Single-channel current was
measured under voltage clamp using a Dagan 3900 ampli¢er (Dagan
Instruments, Minneapolis, MN, USA). Holding potentials were with
respect to the trans (ground) chamber, and positive current was de-
¢ned as current £owing from cis to trans. Current signals were cap-
tured at 10 kHz and ¢ltered at 1 kHz using a four-pole Bessel ¢lter.
Data were digitized with a Digidata 1200 interface (Axon Instru-
ments, Burlingame, CA, USA) and stored on computer for subse-
quent analysis. Unless otherwise stated, test chemicals were sequen-
tially added to the cis solution after an initial period of recording
control channel behavior.
Single-channel activity was analyzed with pCLAMP 7.0 (Axon In-
struments). Current levels were analyzed by mean variance analysis
and peaks in the all-points amplitude histogram were ¢tted with
Gaussian functions. The all-points amplitude histograms were con-
structed from selected segments of data 20^150 s in length to quantify
the incidence of full and subconductance states.
3. Results
The amino acid sequence of MCa is shown in Fig. 1. MCa
shares 82% sequence identity with IpTx A [3], 39% with age-
lenin [13] or Tx2-9 [14], and 27% with g-conotoxin MVIIC
[15] (one scorpion toxin active on RyR1 and RyR2, two spi-
der and one marine snail toxins that block presynaptic P-Q-
type voltage-dependent Ca2 channels). It should be noted
that the Cys residues are similarly arranged in all these pep-
tides. Stepwise assembly of the peptide chains was achieved on
0.25 mmol HMP resin by means of optimized Fmoc/t-butyl
chemistry [10,16]. The amount of target protected peptide
linked to the resin was 0.20 mmol, which represents a yield
of assembly of 80%. The pro¢les of elution by analytical C18
reversed-phase HPLC of the crude reduced peptide after ¢nal
acidolysis are shown in Fig. 2A. The crude peptide was
folded/oxidized by 72 h exposure to air (oxygen as electron
acceptor) (Fig. 2B), and puri¢ed to apparent homogeneity by
preparative C18 reversed-phase HPLC (Fig. 2C). As assessed
by mass spectrometry, the puri¢ed fraction contained two
peptides of experimental Mr (M+H) 3858.2 (sMCa; deduced
Mr (M+H) 3858.5), and 3702.0 (sMCa missing an Arg res-
idue; deduced Mr (M+H) 3702.3). Treatment of this fraction
by ion exchange chromatography (Fig. 2D) resulted in the
separation of the two components and ¢nal recovery of
pure sMCa (Fig. 2E). As assessed by amino acid analysis,
the net peptide content of dried sMCa was 75%. The ¢nal
yield of sMCa synthesis (which combines peptide assembly,
¢nal acidolytic cleavage, folding/oxidation, two-step chroma-
tographic puri¢cation) was about 2% (5 Wmol). Amino acid
contents of sMCa (data not shown), as determined by amino
Fig. 1. Amino acid sequence (one-letter code) of MCa and comparison with other scorpion, spider, and marine snail toxin sequences. The ami-
no acid sequences of g-conotoxin MVIIC from Conus magus marine snail [15], agelenin from A. asperta spider [13], IpTx A from Pandinus
imperator scorpion [3], MCa (underlined) from Scorpio maurus palmatus scorpion [1], and Tx2-9 from P. nigriventer spider [14] were aligned us-
ing the Cys residues critical to the three-dimensional structures of the peptides. Gaps (-) were introduced in the amino acid sequences of these
peptides to maximize homology. The positions of half-cystines are indicated in gray boxes. Amino acid sequence identities are enclosed in open
boxes.
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acid analysis after acidolysis, and experimental Mr (Mr
(M+H) = 3858.2), were in agreement with the deduced val-
ues. To address half-cystine pairings, sMCa was cleaved either
with trypsin or with endoproteinase Asp-N, and the resulting
proteolytic fragments were puri¢ed by HPLC, and character-
ized by means of amino acid analysis, mass spectrometry, and
Edman sequencing techniques. The results of the individual
enzyme treatments are summarized in Fig. 3. The half-cystine
pairings were mapped as Cys3-Cys17, Cys10-Cys21, and
Cys16-Cys32.
Next, we determined the physiological e¡ect and molecular
target of sMCa. Intracerebroventricular injections of sMCa
produced lethal e¡ects in mice. We found an LD50 value of
20 Wg per mouse, which is signi¢cantly less potent than scor-
pion toxins active on Na and K channels. This suggests
that the potential molecular target was not a Na or a K
channel. sMCa had no signi¢cant sequence identity with any
known scorpion toxin except IpTx A [3]. Since IpTx A targets
RyR1 of skeletal muscle, we wanted to determine whether
sMCa was also active on this receptor. To test this hypothesis,
we performed electrophysiological experiments on single
RyR1 channels incorporated into planar lipid bilayers. The
data illustrate that a nanomolar concentration of sMCa ap-
plied on the cis side (cytoplasmic side) dramatically modi¢ed
the channel gating behavior of RyR1 (Fig. 4, traces 1^8). No
e¡ect of the toxin was observed on the trans side (luminal
Fig. 2. Analytical C18 reversed-phase HPLC pro¢les of MCa at various stages of chemical synthesis and ¢nal puri¢cation of sMCa. A: The
crude reduced peptide after tri£uoroacetic acid cleavage. B: The crude peptide after folding/oxidation. C: The peptide fraction ^homogeneous
but impure ^ collected after puri¢cation by C18 reversed-phase HPLC of the crude oxidized peptide. D: Cation exchange HPLC of the peptide
fraction in C. As assessed by mass spectrometry analyses, the peaks at retention times of 44.06 min and 51.65 min correspond to sMCa deleted
of an Arg residue (by-product [vR]sMCa) and sMCa (target peptide), respectively. E: The puri¢ed sMCa obtained after cation exchange
HPLC of impure peptide fraction in C. For conditions, see Section 2.
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side; data not shown) suggesting a cytoplasmic site of action
of the toxin. Of the 12 channels tested, all exhibited similar
responses to sMCa (5 nM to 1 WM) added to the cis chamber.
The predominant action of sMCa was to rapidly induce long-
lived subconductances, mainly having one-half the character-
istic full conductance (traces 1^3). To a lesser extent, conduc-
tances approximating one-quarter the full conductance level
were observed and were evident in the amplitude histograms.
Four out of ¢ve channels modi¢ed by sMCa were shown to be
subsequently modi¢ed by the alkaloid ryanodine (1 WM), con-
¢rming the identity of the channel as RyR1. Five out of six
channels modi¢ed by sMCa were blocked by 10 WM ruthe-
nium red. With both sMCa and ryanodine present, RyR ex-
hibited very stable and long-lived half- and quarter-subcon-
ductances approximating 50.5% and 29.3% of the
characteristic control conductance level (trace 4). Once the
channel was modi¢ed by sMCa and ryanodine, perfusion of
the cis chamber only reversed the sMCa-induced quarter-
states, whereas the ryanodine-mediated half-states persisted
(trace 5), which indicates that ryanodine and sMCa are prob-
ably able to bind simultaneously and on separate sites onto
the RyR1. Re-introduction of sMCa cis resulted in the rapid
reappearance of the stable 51% and 29% conductance transi-
tions (traces 6 and 7). Final addition of ruthenium red com-
pletely blocked the ryanodine/sMCa-modi¢ed channel (trace
8).
4. Discussion
MCa is a 33-residue toxin isolated from the chactid scor-
pion Scorpio maurus palmatus [1]. It is present in minute
amounts in a venom that is seldom collected, thereby preclud-
ing a functional analysis of its biological activity. Because
natural MCa was not available in su⁄cient amounts to inves-
tigate its properties (structure and activity), we performed the
chemical synthesis of this toxin by the solid-phase technique
and fully characterized the synthetic compound.
Interestingly, MCa is peculiar in terms of structural proper-
ties since it does not possess any consensus motif reported so
far in other scorpion toxins [4,5]. It does not fold according to
Fig. 3. Determination of the disul¢de bridges of sMCa. A: Analysis of the peptide fragments obtained by proteolysis of sMCa using either
trypsin or endoproteinase Asp-N. After enzyme-based cleavage, the peptide fragments were puri¢ed by analytical C18 reversed-phase HPLC
and characterized by amino acid analysis, Edman sequencing and mass spectrometry. The peptide sequences deduced from these analyses are
shown. Retention time in HPLC (left column) and established half-cystine pairings (right column) are indicated. B: Complete disul¢de bridge
pattern of sMCa as experimentally determined by enzyme-based cleavage. The positions of half-cystines (bold type) are indicated. The disul¢de
bridges are shown in lines.
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Fig. 4. E¡ects of sMCa on Ca2 release channel/ryanodine receptors incorporated into planar lipid bilayers. sMCa stabilizes subconductance
gating of RyR in a reversible manner. Single channel recording was performed in a 10:1 (cis:trans) CsCl solution at a holding potential of +30
mV. All traces are representative data traces from the same single channel. Trace 1: Control condition with 100 WM Ca 2 and 2 mM ATPNa2
cis. The full subconductance £uctuations predominated as indicated in the all-points amplitude histogram at the right. Traces 2 and 3: Addition
of 50 nM sMCa (trace 2) induced long-lived subconductance gating behavior. The major subconductance induced by sMCa had an amplitude
of 48% of that of full open amplitude. A subconductance having an amplitude approximately 29% of the full level was also evident in sMCa-
modi¢ed channels (trace 3). Trace 4: Further addition of 1 WM ryanodine to the sMCa-modi¢ed channel induced characteristic long half con-
ductance gating in addition to the smaller subconductance level (31.5%), indicating the coexistence of ryanodine and sMCa binding. Trace 5:
Ryanodine and sMCa were removed from the cis chamber by perfusion with 9U volume of drug-free solution (500 mM CsCl, V7 WM Ca2,
20 mM HEPES). After perfusion was complete, the channel exhibited only the half conductance gating transitions as would be expected from
irreversible modi¢cation by WM ryanodine. Traces 6 and 7: Subsequent re-introduction of 50 nM sMCa in the cis chamber induced the reap-
pearance of smaller subconductance transitions with 19.7% and 29.9% of the full amplitude. Trace 8: Final addition of 10 WM ruthenium red
to the ryanodine/sMCa-modi¢ed channel completely eliminated gating activity.
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the ‘common’ K/L sca¡old of toxins acting on either sodium,
potassium and chloride channels [17,18]. In contrast, it was
found that MCa folds according to the ‘inhibitor cystine knot’
motif which is also present in natural toxins acting on voltage-
dependent Ca2 channels such as spider and marine snail
toxins (various W-agatoxins and g-conotoxins) [19,20]. The
disul¢de bridge pattern of sMCa was established by enzyme-
based cleavage and analysis of the proteolytic peptide frag-
ments thus obtained. The main di⁄culty in determining the
half-cystine pairings of sMCa was the presence of a pair of
contiguous half-cystines in positions 16 and 17, which did not
permit cleavage between all the six half-cystines, and therefore
prevented the use of the classical method of half-cystine pair-
ing determination. Instead, the use of a new method [21]
based on Edman sequencing has allowed formal identi¢cation
of the three disul¢de bridges. The disul¢de bridges found in
MCa linked half-cystines 3 and 17, 10 and 21 and 16 and 32.
It should be noted that a similar disul¢de bridge organization
has been attributed to g-conotoxins active on voltage-depen-
dent Ca2 channels [22].
The structural homology of MCa with toxins from other
animal species is further coupled with a similarity in function-
al activity since we found that the toxin acts on RyR1 isolated
from skeletal muscle SR. It is striking that the apparent bio-
logical target of MCa is located intracellularly. However, it
should be noted that this is not the ¢rst example of a scorpion
toxin acting on RyR1. Scorpion toxin IpTx A is also a high-
a⁄nity activator of this channel type. This may not be so
surprising since MCa shares 82% sequence identity with
IpTx A. Also, it is likely that IpTx A folds according to a
similar half-cystine pairing pattern as MCa although it has
not been formally established in the case of this toxin. It is
generally believed that these toxins are unable to cross the
plasma membrane and that, therefore, the intracellular targets
identi¢ed do not represent real targets but mimicking recep-
tors. Notwithstanding, it should be emphasized that the ex-
treme basicity of these toxins (e.g. MCa and IpTx A possess a
net charge of +7 at physiological pH value) would make
sMCa a good candidate to permeate the membrane [23]. It
is also generally agreed that highly basic peptides translocate
to the cytosol by locally disrupting the integrity of the lipid
bilayer [24]. This membrane-crossing activity presumably re-
sults from an interaction of the positively charged moieties of
basic residues with negatively charged polar heads of fatty
acids of the plasma membrane.
Our data show that sMCa added to the cytoplasmic com-
partment (cis side of the skeletal RyR1) induces the appear-
ance of subconductance states corresponding to about 51%
and 29% of the typical full conductance seen with RyR1. A
similar observation has been made for the action of IpTx A
[25]. The data also suggest that the peptide is able to simulta-
neously bind to the RyR1 receptor together with ryanodine.
This result was not surprising since it has been reported that
IpTx A is capable of enhancing [3H]ryanodine binding [26].
Since sMCa induces the appearance of long-lived subconduc-
tance, in a similar though not identical manner as IpTx A, it is
expected to induce net Ca2 release from the SR. In this
regard, sMCa di¡ers from IpTx A in that it stabilizes multiple
conductance states whereas the latter seems to favor only the
1/3 conductance state [25]. It has recently been noted that
IpTx A shares structural homology with a segment of the
II^III loop of the skeletal muscle dihydropyridine receptor
(K1S subunit) that has been proposed to act as an activator
of the RyR1. This homology concerns a cluster of basic amino
acid residues (KKCKRR motif) at positions 19^24. Based on
this observation, it was proposed that IpTx A is a peptide
mimetic of the dihydropyridine receptor II^III loop, itself an
endogenous e¡ector structure that is crucial for excitation^
contraction coupling. Remarkably, this basic motif was en-
tirely conserved in MCa. The similarities in structure and
function between IpTx A and MCa suggest that they may
share the same binding site onto RyR1 and that this site could
overlap a potential excitation^contraction signal transduction
locus [26]. The binding site of IpTx A has been located to the
cytoplasmic moiety of RyR1 between the clamp and handle
domains [7], away from the transmembrane pore, supporting
an allosteric mechanism of action of these toxins as opposed
to the one involving direct positioning within the ion conduct-
ing channel. It is therefore expected that MCa will also be
useful to study the molecular determinants of excitation^con-
traction coupling and the chain of conformational events
leading to the opening of RyR1.
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